-+ 0.00%
-+ 0.00%
-+ 0.00%

Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity

Barchart·08/10/2026 07:32:00
Listen to the news

– Publication details the discovery and preclinical characterization of ziftomenib, including its potency, selectivity, and mechanism of action

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.